Dr. Prashant Vilas Bhangui

26/07/2026

https://www.instagram.com/reel/DbHrJ0YRNYY/?utm_source=ig_web_copy_link&igsh=MzRlODBiNWFlZA==

25/06/2026

We are proud to celebrate Dr. Prashant Bhangui, Director – Liver Transplant, Medanta, Gurugram, whose contributions to liver transplantation, hepatobiliary surgery, and clinical research continue to advance the boundaries of transplant medicine.

A highly respected transplant surgeon, researcher, teacher and innovator, Dr. Bhangui has been instrumental in managing some of the most complex liver transplant cases and advancing surgical techniques that have helped improve outcomes for patients in India and across the world. His work in the field of Transplant Oncology has made him a global key opinion leader leading guideline formulation and consensus for the same. His work reflects a deep commitment to clinical excellence, innovation, and evidence-based care.

In recognition of his outstanding scientific contributions, Dr. Prashant Vilas Bhangui has been independently ranked among the World's Top 5% Scientists in the 2025 SciRank Global Registry.

The SciRank Global Registry evaluates researchers through rigorous bibliometric analysis, measuring the quality, impact, and influence of their scholarly work. This prestigious recognition reflects Dr. Bhangui's dedication to research excellence and his continued efforts to advance the field of liver transplantation and hepatobiliary surgery.

We congratulate Dr. Bhangui on this remarkable global achievement and are proud to celebrate this milestone with him.

17/06/2026

Incredibly proud to be recognized in the SciRank Global 2025 Official Registry as one of the World's Top 5% Scientists! 🔬

Huge thanks to my peers and the community at Medanta The Medicity. This milestone only motivates me to keep driving impactful research forward.

08/05/2026

A new chapter for ILTS leadership begins in Geneva.

At the 30th Annual ILTS Congress, we are proud to introduce the 2026–2027 ILTS Council — the team that will guide the society through another year of scientific advancement, global collaboration, and community growth.

A warm welcome to our incoming council members: Simone Strasser, Davide Ghinolfi, Lucas McCormack, and Anjana Pillai — we look forward to the contributions you will bring to this community.

To all council members, thank you for your continued dedication to advancing liver transplantation worldwide.

New ILTS members joining during the congress are entered into a draw to win free registration to ILTS 2027 in Montreal. Join today: ilts.org/membership

29/04/2026

I recently spoke on Goa 365 about the increasing prevalence of liver disease in India and advances in liver transplantation.

We discussed the importance of metabolic health, early detection, and timely specialist referral, along with the safety and success of living donor transplants.

🎥 Watch the full interview: https://youtu.be/IpxwDPYonHY

Dr. Prashant Bhangui
Director & Senior Surgeon, Liver Transplant and Hepatobiliary Surgery, Medanta Hospitals

4 likes. "Talk from the Heart || Liver health for all with Dr. Prashant Bhangui"

28/04/2026

https://youtu.be/IpxwDPYonHY

27/04/2026

19/04/2026

Dr. Prashant Bhangui, Director of Liver Transplant and Regenerative Medicine at Medanta, is conducting specialized consultations in Qarshi, Uzbekistan, on April 20th and 21st, 2026. Hosted at the Dr. Oybek KO'Z KLINIKASI (EVRO MED + KLINIKA), this session offers expert clinical evaluation for conditions including liver cirrhosis, chronic liver disease, and various hepatic cancers.

Patients seeking advanced surgical or transplant guidance can book an appointment by contacting +998 888105 566 or +998 909624 428.

18/04/2026

The landscape of liver cancer treatment is shifting from "end of the road" to a new era of survivability.

In this insightful interview with The Navhind Times, Dr. Prashant Bhangui (Director of Hepatobiliary Surgery and Liver Transplantation at Medanta, Gurugram) discusses the revolutionary role of liver transplants and immunotherapy in treating HCC.

Early intervention is the cornerstone of survival. Read the full interview to understand the latest breakthroughs in hepatobiliary surgery.